Truncated neurokinin1 receptor is an ubiquitous antitumor target in hepatoblastoma, and its expression is independent of tumor biology and stage

Author：              

Publisher： Spandidos Publications

E-ISSN： 1792-1082|11|1|870-878

ISSN： 1792-1074

Source： Oncology Letters, Vol.11, Iss.1, 2016-01, pp. : 870-878

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antitumor activity of neurokinin-1 receptor antagonists in MG-63 human osteosarcoma xenografts

By            

International Journal of Oncology, Vol. 44, Iss. 1, 2014-01 ,pp. : 137-146

Spandidos Publications

Access to resources Recommend Favorite

Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression

By Gustafsson Annika   Hansson Elisabeth   Kressner Ulf   Nordgren Svante   Andersson Marianne   Lönnroth Christina   Lundholm Kent  

Acta Oncologica, Vol. 46, Iss. 8, 2007-01 ,pp. : 1107-1112

Informa Healthcare

Access to resources Recommend Favorite

BRCA-FA Pathway as a Target for Anti-Tumor Drugs

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 4, 2008-05 ,pp. : 426-430

Bentham Science Publishers

Access to resources Recommend Favorite

The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer

By              

International Journal of Oncology, Vol. 45, Iss. 4, 2014-01 ,pp. : 1658-1672

Spandidos Publications

Access to resources Recommend Favorite

Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells

By                

International Journal of Oncology, Vol. 47, Iss. 1, 2015-01 ,pp. : 151-160

Spandidos Publications

Access to resources Recommend Favorite